Genscript Biotech Corp. (GNNSF)
4.50
+0.25
(+5.88%)
USD |
OTCM |
Oct 28, 16:00
Genscript Biotech Market Cap : 9.684B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 9.684B |
| October 27, 2026 | 9.146B |
| October 26, 2026 | 9.146B |
| October 23, 2026 | 9.146B |
| October 22, 2026 | 8.985B |
| October 21, 2026 | 8.985B |
| October 20, 2026 | 8.985B |
| October 19, 2026 | 8.985B |
| October 16, 2026 | 8.985B |
| October 15, 2026 | 8.716B |
| October 14, 2026 | 9.749B |
| October 13, 2026 | 9.749B |
| October 12, 2026 | 11.84B |
| October 09, 2026 | 11.19B |
| October 08, 2026 | 11.31B |
| October 07, 2026 | 12.48B |
| October 06, 2026 | 13.67B |
| October 05, 2026 | 12.48B |
| October 02, 2026 | 11.88B |
| October 01, 2026 | 12.27B |
| September 30, 2026 | 11.89B |
| September 29, 2026 | 11.51B |
| September 28, 2026 | 11.51B |
| September 25, 2026 | 10.87B |
| September 24, 2026 | 10.87B |
| Date | Value |
|---|---|
| September 23, 2026 | 12.16B |
| September 22, 2026 | 12.16B |
| September 21, 2026 | 12.16B |
| September 18, 2026 | 10.37B |
| September 17, 2026 | 8.823B |
| September 16, 2026 | 8.823B |
| September 15, 2026 | 8.823B |
| September 14, 2026 | 8.823B |
| September 11, 2026 | 8.823B |
| September 10, 2026 | 8.966B |
| September 09, 2026 | 8.747B |
| September 08, 2026 | 8.747B |
| September 04, 2026 | 8.747B |
| September 03, 2026 | 9.404B |
| September 02, 2026 | 10.17B |
| September 01, 2026 | 10.17B |
| August 31, 2026 | 9.622B |
| August 28, 2026 | 9.841B |
| August 27, 2026 | 9.842B |
| August 26, 2026 | 9.075B |
| August 25, 2026 | 10.06B |
| August 24, 2026 | 8.747B |
| August 21, 2026 | 8.441B |
| August 20, 2026 | 8.441B |
| August 19, 2026 | 8.091B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Charles River Laboratories International, Inc. | 17.95B |
| Trajan Group Holdings Ltd. | 30.57M |
| Fortrea Holdings, Inc. | 2.200B |
| ICON plc | 16.64B |
| IQVIA Holdings, Inc. | 45.24B |
Market Cap Related Metrics
| PS Ratio | 11.57 |
| PEG Ratio | -0.0609 |
| Price to Free Cash Flow | 147.80 |
| Price | 4.50 |
| Earnings Yield | -6.53% |
| PEGY Ratio | -0.0609 |
| Operating PE Ratio | 93.83 |